A study of interleukin-10 (IL-10) promoter gene polymorphisms and response to therapy in chronic hepatitis C infection in children

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

IL28B gene polymorphism and spontaneous hepatitis C virus clearance in sickle cell disease patients

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Interleukin 28 B genotype as a predictor of response to therapy with pegylated interferon plus ribavirin in HCV infected Egyptian patients

Evaluation of different laboratory tests as predictors to the response for interferon therapy in chronic hepatitis c virus patients